Susquehanna Fundamental Investments, LLC Aveo Pharmaceuticals, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$6.61 - $8.72 $225,110 - $296,968	-34,056 Reduced 72.17%	13,130 $108,000
Q4 2021 Feb 14, 2022	SELL	$4.69 - $7.4 $107,841 - $170,155	-22,994 Reduced 32.76%	47,186 $221,000
Q3 2021 Nov 15, 2021	BUY	$5.12 - $6.89 $64,921 - $87,365	12,680 Added 22.05%	70,180 $434,000
Q2 2021 Aug 11, 2021	BUY	$6.21 - $7.45 $357,075 - $428,375	57,500 New	57,500 $379,000

Ticker AVEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,676,000
Description
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.